Kihara James bought ACAD
May 1, 2026 · Form 4 insider transaction
Kihara James bought 2,596 shares of ACADIA Pharmaceuticals Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,596
Price
N/A
Total value
N/A
InsiderKihara James
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 1, 2026
Filing dateMay 5, 2026
Shares owned after30,461
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.